Dendreon Planning To Launch DACS Stem Cell Separator In Six Months

Dendreon is seeking a corporate partner to assist in marketing its DACS stem cell device for debulking and enriching hematopoietic stem cells for reconstitution of immune systems of patients undergoing chemotherapy.